Responses
Regular and young investigator award abstracts
Cellular therapies
96 Decitabine gene modulation sensitizes human non–small cell lung cancer (NSCLC) to NY-ESO-1 TCR immunotherapy (letetresgene autoleucel; GSK3377794) in vivo
Compose a Response to This Article
Other responses
No responses have been published for this article.
